Redox-mediated activation of latent transforming growth factor-beta 1.
Transforming growth factor beta 1 (TGF beta) is a multifunctional cytokine that orchestrates response to injury via ubiquitous cell surface receptors. The biological activity of TGF beta is restrained by its secretion as a latent complex (LTGF beta) such that activation determines the extent of TGF beta activity during physiological and pathological events. TGF beta action has been implicated in a variety of reactive oxygen-mediated tissue processes, particularly inflammation, and in pathologies such as reperfusion injury, rheumatoid arthritis, and atherosclerosis. It was recently shown to be rapidly activated after in vivo radiation exposure, which also generates reactive oxygen species (ROS). In the present studies, the potential for redox-mediated LTGF beta activation was investigated using a cell-free system in which ROS were generated in solution by ionizing radiation or metal ion-catalyzed ascorbate reaction. Irradiation (100 Gray) of recombinant human LTGF beta in solution induced 26% activation compared with that elicited by standard thermal activation. Metal-catalyzed ascorbate oxidation elicited extremely efficient recombinant LTGF beta activation that matched or exceeded thermal activation. The efficiency of ascorbate activation depended on ascorbate concentrations and the presence of transition metal ions. We postulate that oxidation of specific amino acids in the latency-conferring peptide leads to a conformation change in the latent complex that allows release of TGF beta. Oxidative activation offers a novel route for the involvement of TGF beta in tissue processes in which ROS are implicated and endows LTGF beta with the ability to act as a sensor of oxidative stress and, by releasing TGF beta, to function as a signal for orchestrating the response of multiple cell types. LTGF beta redox sensitivity is presumably directed toward recovery of homeostasis; however, oxidation may also be a mechanism of LTGF beta activation that can be deleterious during disease mechanisms involving chronic ROS production.
Barcellos-Hoff
M H
MH
Life Sciences Division, Ernest O. Lawrence Berkeley National Laboratory, University of California, Berkeley 94720, USA.
Dix
T A
TA
D000818:Animals; D001205:Ascorbic Acid / Q000737:chemistry / Q000378:metabolism; D002614:Chelating Agents / Q000737:chemistry / Q000378:metabolism; D004789:Enzyme Activation / Q000528:radiation effects; D004847:Epithelial Cells; D004848:Epithelium / Q000378:metabolism; D007477:Ions; D008168:Lung / Q000166:cytology / Q000378:metabolism; D008670:Metals / Q000737:chemistry / Q000378:metabolism; D008907:Mink; D008954:Models, Biological; D010084:Oxidation-Reduction; D011487:Protein Conformation; D017382:Reactive Oxygen Species / Q000378:metabolism; D011994:Recombinant Proteins / Q000737:chemistry / Q000378:metabolism / Q000528:radiation effects; D013696:Temperature; D016212:Transforming Growth Factor beta / Q000187:drug effects / Q000378:metabolism* / Q000528:radiation effects
D002614:Chelating Agents; D007477:Ions; D008670:Metals; D017382:Reactive Oxygen Species; D011994:Recombinant Proteins; D016212:Transforming Growth Factor beta; D001205:Ascorbic Acid